Article Versions Notes

Hosui A, Hayata N, Kurahashi T, Namiki A, Okamoto A, Aochi K, Ashida M, Tanimoto T, Murai H, Ohnishi K, et al. Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC. Cancers. 2025; 17(2):185. https://doi.org/10.3390/cancers17020185

Hosui, Atsushi, Naoko Hayata, Tomohide Kurahashi, Akane Namiki, Akino Okamoto, Kazuki Aochi, Munehiro Ashida, Takafumi Tanimoto, Hiroki Murai, Kohsaku Ohnishi, and et al. 2025. "Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC" Cancers 17, no. 2: 185. https://doi.org/10.3390/cancers17020185

Hosui, A., Hayata, N., Kurahashi, T., Namiki, A., Okamoto, A., Aochi, K., Ashida, M., Tanimoto, T., Murai, H., Ohnishi, K., Hirao, M., Yamada, T., & Hiramatsu, N. (2025). Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC. Cancers, 17(2), 185. https://doi.org/10.3390/cancers17020185